Earnings Driven by Focused Execution and 22% Op Revenue Growth of Launched and Acquired Products(1)Pipeline Momentum Builds on Positive Phase 3 and Mid-Stage ReadoutsRobust Late‑Stage R&D Pipeline, On ...
Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in ...
Morning Overview on MSN
Pfizer settles patent fights, keeping heart drug shielded from generics to 2031
Patients taking Pfizer’s Vyndaqel and Vyndamax for a progressive, often fatal form of heart failure will not see cheaper ...
The MarketWatch News Department was not involved in the creation of this content. -- Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results